An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Almost 20 years ago, a hallway conversation kickstarted Dr. Mansoor Husain’s journey in helping create and test a new diabetes drug that reduces the risk of heart disease.
In 2019, the Ted Rogers Centre for Heart Research executive director published the findings of a landmark trial proving the drug’s safety and reduction in cardiovascular-related mortality, bringing a new therapy into the fold for patients with diabetes – who are two to four times more likely to die from cardiovascular problems than those without it.
In this podcast, produced by University Health Network, explore the fascinating intersection of type 2 diabetes and heart failure, and the recent journey to discover that treatments for the former can be effective for the latter.